Amplia Therapeutics Ltd.ASX: ATX

First Patient Recruited to ACCENT Trial in Pancreatic Cancer

Aug 2, 2022 at 6:14 AM UTC · Issued by Amplia Therapeutics Ltd.

Amplia Therapeutics Ltd has released a press release.

View Attachment